California State Teachers Retirement System Gemini Therapeutics, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.22 - $1.73 $11,808 - $16,744	-9,679 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.29 - $3.08 $1,549 - $3,699	-1,201 Reduced 11.04%	9,679 $13,000
Q4 2021 Feb 15, 2022	SELL	$2.39 - $4.0 $8,506 - $14,236	-3,559 Reduced 24.65%	10,880 $32,000
Q3 2021 Nov 15, 2021	SELL	$3.3 - $6.32 $52,169 - $99,912	-15,809 Reduced 52.26%	14,439 $58,000
Q2 2021 Aug 16, 2021	BUY	$6.32 - $14.02 $191,167 - $424,076	30,248 New	30,248 $196,000

Others Institutions Holding GMTX

# of Institutions

Shares Held

2.44M

Call Options Held

Put Options Held

Foresite Capital Opportunity Management V, LLC Larkspur, CA

2.44M
Shares

$59.3 Million
11.99% of portfolio

View Full List

About Gemini Therapeutics, Inc.

Ticker GMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,244,500
Market Cap $1.05B
Description
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...

More about GMTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account